Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mr V Z Cooling 23/03/2021 Dr N J Cooling 23/03/2021 16 December 2025 The principal activity of the Company during the financial period was property rental. 13285788 2025-03-31 13285788 bus:Director1 2025-03-31 13285788 bus:Director2 2025-03-31 13285788 2024-03-31 13285788 core:CurrentFinancialInstruments 2025-03-31 13285788 core:CurrentFinancialInstruments 2024-03-31 13285788 core:ShareCapital 2025-03-31 13285788 core:ShareCapital 2024-03-31 13285788 core:RetainedEarningsAccumulatedLosses 2025-03-31 13285788 core:RetainedEarningsAccumulatedLosses 2024-03-31 13285788 core:LandBuildings 2024-03-31 13285788 core:LandBuildings 2025-03-31 13285788 core:CostValuation 2024-03-31 13285788 core:CostValuation 2025-03-31 13285788 bus:OrdinaryShareClass1 2025-03-31 13285788 bus:OrdinaryShareClass2 2025-03-31 13285788 bus:OrdinaryShareClass3 2025-03-31 13285788 2024-04-01 2025-03-31 13285788 bus:FilletedAccounts 2024-04-01 2025-03-31 13285788 bus:SmallEntities 2024-04-01 2025-03-31 13285788 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13285788 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13285788 bus:Director1 2024-04-01 2025-03-31 13285788 bus:Director2 2024-04-01 2025-03-31 13285788 core:LandBuildings core:TopRangeValue 2024-04-01 2025-03-31 13285788 2023-04-01 2024-03-31 13285788 core:LandBuildings 2024-04-01 2025-03-31 13285788 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 13285788 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 13285788 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 13285788 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 13285788 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 13285788 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 13285788 (England and Wales)

TEIGNMOUTH MEDICO-LEGAL LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

TEIGNMOUTH MEDICO-LEGAL LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

TEIGNMOUTH MEDICO-LEGAL LIMITED

BALANCE SHEET

As at 31 March 2025
TEIGNMOUTH MEDICO-LEGAL LIMITED

BALANCE SHEET (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 378,659 384,733
Investments 4 160 160
378,819 384,893
Current assets
Debtors 5 60 109
Cash at bank and in hand 37,486 29,194
37,546 29,303
Creditors: amounts falling due within one year 6 ( 413,104) ( 411,889)
Net current liabilities (375,558) (382,586)
Total assets less current liabilities 3,261 2,307
Net assets 3,261 2,307
Capital and reserves
Called-up share capital 7 160 160
Profit and loss account 3,101 2,147
Total shareholders' funds 3,261 2,307

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Teignmouth Medico-Legal Limited (registered number: 13285788) were approved and authorised for issue by the Board of Directors on 16 December 2025. They were signed on its behalf by:

Dr N J Cooling
Director
TEIGNMOUTH MEDICO-LEGAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
TEIGNMOUTH MEDICO-LEGAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Teignmouth Medico-Legal Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Hill View Ringmore, Shaldon, Teignmouth, TQ14 0ES, England, United Kingdom.

The financial statements have been prepared under the historical cost convention and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the company and rounded to the nearest £.

Going concern

Notwithstanding the net liabilities of £375,558 (2024: £382,586), the directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. Included within creditors due within one year is a loan from its wholly owned subsidiary of £408,286 (2024: £408,286) and the directors have received assurances that the subsidiary will continue to support the Company for the foreseeable future. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Group accounts exemption

Group accounts exemption s399
The Company has taken advantage of the exemption in section 399 of the Companies Act 2006 not to prepare consolidated accounts, because the group it heads qualifies as small. The financial statements present information about the Company as an individual entity only.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Rental income is recognised in accordance with the lease.

Dividend income

Dividend income is recognised when the company's right to receive payment has been established.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Land and buildings 50 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Investments
Investments in non-convertible preference shares and non-puttable ordinary or preference shares (where shares are publicly traded or their fair value is reliably measurable) are measured at fair value through the Statement of Income and Retained Earnings. Where fair value cannot be measured reliably, investments are measured at cost less impairment.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Land and buildings Total
£ £
Cost
At 01 April 2024 399,916 399,916
At 31 March 2025 399,916 399,916
Accumulated depreciation
At 01 April 2024 15,183 15,183
Charge for the financial year 6,074 6,074
At 31 March 2025 21,257 21,257
Net book value
At 31 March 2025 378,659 378,659
At 31 March 2024 384,733 384,733

4. Fixed asset investments

Investments in subsidiaries

2025
£
Cost
At 01 April 2024 160
At 31 March 2025 160
Carrying value at 31 March 2025 160
Carrying value at 31 March 2024 160

5. Debtors

2025 2024
£ £
Other debtors 60 109

6. Creditors: amounts falling due within one year

2025 2024
£ £
Amounts owed to Group undertakings 408,286 408,286
Taxation and social security 1,719 754
Other creditors 3,099 2,849
413,104 411,889

7. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
100 Ordinary A shares of £ 1.00 each 100 100
40 Ordinary B shares of £ 1.00 each 40 40
20 Ordinary C shares of £ 1.00 each 20 20
160 160